{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:31:34Z","timestamp":1770838294235,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.expneurol.2004.03.018","type":"journal-article","created":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T09:50:07Z","timestamp":1083405007000},"page":"161-170","source":"Crossref","is-referenced-by-count":16,"title":["Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity"],"prefix":"10.1016","volume":"188","author":[{"given":"Tomoko","family":"Sengoku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimala","family":"Bondada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane","family":"Hassane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Dubal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.03.018_BIB1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00401-002-0528-6","article-title":"Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2","volume":"104","author":"Adamec","year":"2002","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0016-5085(94)90600-9","article-title":"The endocytosis of transferrin by rat intestinal epithelial cells","volume":"106","author":"Anderson","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB4","first-page":"63","article-title":"Translocation of human platelet calpain-I","volume":"30","author":"Ariyoshi","year":"1993","journal-title":"Biochem. Mol. Biol. Int"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB5","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1073\/pnas.262460299","article-title":"Protection against ischemic brain injury by protein therapeutics","volume":"99","author":"Asoh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/jcbfm.1994.67","article-title":"Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage","volume":"14","author":"Bartus","year":"1994","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/syn.890010603","article-title":"Subcellular compartmentalization of calcium-dependent and calcium-independent neutral proteases in brain","volume":"1","author":"Baudry","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/meth.2001.1186","article-title":"TAT-mediated protein transduction into mammalian cells","volume":"24","author":"Becker-Hapak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jnr.490350513","article-title":"Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination","volume":"35","author":"Brewer","year":"1993","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB10","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1523\/JNEUROSCI.22-13-05423.2002","article-title":"In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis","volume":"22","author":"Cao","year":"2002","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00971321","article-title":"The regional and subcellular distribution of calcium activated neutral proteinase (CANP) in the bovine central nervous system","volume":"14","author":"Chakrabarti","year":"1989","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/(SICI)1097-4547(19970315)47:6<609::AID-JNR6>3.0.CO;2-H","article-title":"Immunolocalization of cytoplasmic and myelin mcalpain in transfected Schwann cells: II. Effect of withdrawal of growth factors","volume":"47","author":"Chakrabarti","year":"1997","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/physrev.1991.71.3.813","article-title":"Calcium-activated neutral protease (calpain) system: structure, function, and regulation","volume":"71","author":"Croall","year":"1991","journal-title":"Physiol. Rev"},{"issue":"Pt. 2","key":"10.1016\/j.expneurol.2004.03.018_BIB14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/0264-6021:3430467","article-title":"Changes in intracellular localization of calpastatin during calpain activation","volume":"343","author":"De Tullio","year":"1999","journal-title":"Biochem. J"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/mcne.2002.1165","article-title":"Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction","volume":"21","author":"Dietz","year":"2002","journal-title":"Mol. Cell. Neurosci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12031-002-0024-4","article-title":"Calpain inhibitors: a treatment for Alzheimer's disease","volume":"19","author":"Di Rosa","year":"2002","journal-title":"J. Mol. Neurosci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2174\/0929867003374129","article-title":"A survey of calpain inhibitors","volume":"7","author":"Donkor","year":"2000","journal-title":"Curr. Med. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0196-9781(97)00242-8","article-title":"Bioavailability and transport of peptides and peptide drugs into the brain","volume":"18","author":"Egleton","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB19","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0021-9258(18)69215-4","article-title":"All four repeating domains of the endogenous inhibitor for calcium-dependent protease independently retain inhibitory activity. Expression of the cDNA fragments in Escherichia coli","volume":"263","author":"Emori","year":"1988","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB20","doi-asserted-by":"crossref","first-page":"12625","DOI":"10.1074\/jbc.M311461200","article-title":"A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides","volume":"279","author":"Fischer","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.gt.3301383","article-title":"Protein transduction: an alternative to genetic intervention?","volume":"8","author":"Ford","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1389203033487261","article-title":"Structural variety of membrane permeable peptides","volume":"4","author":"Futaki","year":"2003","journal-title":"Curr. Protein Pept. Sci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB23","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1515\/BC.2003.045","article-title":"Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin","volume":"384","author":"Gil-Parrado","year":"2003","journal-title":"Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00029.2002","article-title":"The calpain system","volume":"83","author":"Goll","year":"2003","journal-title":"Physiol. Rev"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1271\/bbb.62.136","article-title":"Expression of biologically active human calpastatin in baculovirus-infected insect cells and in Escherichia coli","volume":"62","author":"Hitomi","year":"1998","journal-title":"Biosci., Biotechnol., Biochem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bbrc.2003.09.142","article-title":"Association of the calpain\/calpastatin network with subcellular organelles","volume":"310","author":"Hood","year":"2003","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1471-4914(01)02049-4","article-title":"The calpain family and human disease","volume":"7","author":"Huang","year":"2001","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.0000066869.45310.50","article-title":"Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice","volume":"34","author":"Kilic","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB30","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","article-title":"Caspase 3-cleaved N-terminal fragments of wild-type and mutant Huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB31","doi-asserted-by":"crossref","first-page":"41890","DOI":"10.1074\/jbc.M306017200","article-title":"Parkin cleaves intracellular alpha-synuclein's inclusions via the activation of calpain","volume":"278","author":"Kim","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/089771501317095269","article-title":"The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury","volume":"18","author":"Kupina","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(00)02215-8","article-title":"Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells","volume":"485","author":"Kwon","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/90741","article-title":"Is VP22 nuclear homing an artifact?","volume":"19","author":"Lundberg","year":"2001","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0014-5793(87)80531-8","article-title":"All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II","volume":"223","author":"Maki","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB36","doi-asserted-by":"crossref","first-page":"18866","DOI":"10.1016\/S0021-9258(19)47235-9","article-title":"Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene","volume":"264","author":"Maki","year":"1989","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB37","first-page":"509","article-title":"Calpastatins: biochemical and molecular biological studies","volume":"50","author":"Maki","year":"1991","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/01.STR.29.1.152","article-title":"Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats","volume":"29","author":"Markgraf","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0968-0004(91)90058-4","article-title":"Cell-penetrating inhibitors of calpain","volume":"16","author":"Mehdi","year":"1991","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB40","doi-asserted-by":"crossref","first-page":"29899","DOI":"10.1074\/jbc.272.47.29899","article-title":"Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome","volume":"272","author":"Mellgren","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-5793(98)00724-8","article-title":"Properties of calpastatin forms in rat brain","volume":"431","author":"Melloni","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(98)00921-4","article-title":"Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia","volume":"810","author":"Minger","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB43","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1471-4159.2003.01878.x","article-title":"Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro","volume":"86","author":"Mishizen-Eberz","year":"2003","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/4042","article-title":"Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration","volume":"4","author":"Nagahara","year":"1998","journal-title":"Nat. Med"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0006-291X(03)00807-6","article-title":"Intracellular delivery of glutathione S-transferase into mammalian cells","volume":"305","author":"Namiki","year":"2003","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB46","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JVI.70.3.1475-1480.1996","article-title":"Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic","volume":"70","author":"Nath","year":"1996","journal-title":"J. Virol"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/neu.1997.14.369","article-title":"Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat","volume":"14","author":"Newcomb","year":"1997","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.1994.tb44402.x","article-title":"Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease","volume":"747","author":"Nixon","year":"1994","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB49","series-title":"Calpain: Pharmacology and Toxicology of Calcium-Dependent Protease","first-page":"1","article-title":"The calpain superfamily","author":"Ono","year":"1999"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/syn.890020111","article-title":"The ultrastructural localization of calcium-activated protease \u201ccalpain\u201d in rat brain","volume":"2","author":"Perlmutter","year":"1988","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB51","doi-asserted-by":"crossref","first-page":"50188","DOI":"10.1074\/jbc.M308719200","article-title":"Cytoplasmic and nuclear delivery of a TAT-derived peptide and a {beta}-peptide after endocytic uptake into HeLa cells","volume":"278","author":"Potocky","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/pr.54.4.561","article-title":"Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway","volume":"54","author":"Qian","year":"2002","journal-title":"Pharmacol. Rev"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1568007033482887","article-title":"Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration","volume":"2","author":"Ray","year":"2003","journal-title":"Curr. Drug Targets CNS Neurol. Disord"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0173(03)00152-8","article-title":"Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors","volume":"42","author":"Ray","year":"2003","journal-title":"Brain Res. Brain Res. Rev"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB55","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB56","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1523\/JNEUROSCI.14-06-03934.1994","article-title":"Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain","volume":"14","author":"Roberts-Lewis","year":"1994","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB57","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/00005072-199607000-00010","article-title":"Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat","volume":"55","author":"Saatman","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004647-200001000-00010","article-title":"Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis","volume":"20","author":"Saatman","year":"2000","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB59","doi-asserted-by":"crossref","first-page":"25239","DOI":"10.1016\/S0021-9258(19)74593-1","article-title":"Spatial resolution of fodrin proteolysis in postischemic brain","volume":"268","author":"Saido","year":"1993","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1432-1033.1995.tb20529.x","article-title":"Identification and characterization of membrane-bound calpains in clathrin-coated vesicles from bovine brain","volume":"230","author":"Sato","year":"1995","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB61","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB62","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0962-8924(00)01771-2","article-title":"Protein transduction: unrestricted delivery into all cells?","volume":"10","author":"Schwarze","year":"2000","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0896-6273(88)90076-1","article-title":"Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo","volume":"1","author":"Siman","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB64","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1523\/JNEUROSCI.09-05-01579.1989","article-title":"Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage","volume":"9","author":"Siman","year":"1989","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB65","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1046\/j.1471-4159.1997.69041592.x","article-title":"Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment","volume":"69","author":"Springer","year":"1997","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB66","first-page":"633","article-title":"Multiple forms of calpastatin in pig brain","volume":"19","author":"Takano","year":"1989","journal-title":"Biochem. Int"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB67","first-page":"517","article-title":"Molecular diversity of erythrocyte calpastatin","volume":"50","author":"Takano","year":"1991","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/oxfordjournals.jbchem.a022733","article-title":"Four types of calpastatin isoforms with distinct amino-terminal sequences are specified by alternative first exons and differentially expressed in mouse tissues","volume":"128","author":"Takano","year":"2000","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB69","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1471-4159.1992.tb11374.x","article-title":"Immunoassay and activity of calcium-activated neutral proteinase (mCANP): distribution in soluble and membrane-associated fractions in human and mouse brain","volume":"58","author":"Takeuchi","year":"1992","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB70","first-page":"491","article-title":"Immunolocalization of the calpains and calpastatin in human and bovine platelets","volume":"50","author":"Taylor","year":"1991","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/abio.1999.4475","article-title":"A BODIPY fluorescent microplate assay for measuring activity of calpains and other proteases","volume":"279","author":"Thompson","year":"2000","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/10611869808997889","article-title":"Estimation of blood\u2013brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors","volume":"6","author":"van de Waterbeemd","year":"1998","journal-title":"J. Drug Targeting"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB73","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.HYP.0000047878.13793.41","article-title":"Transduction of a functional domain of the AT1 receptor in neurons by HIV-Tat PTD","volume":"41","author":"Vazquez","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB74","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Vives","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB75","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1097\/00001756-200112040-00008","article-title":"Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis","volume":"12","author":"Volbracht","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB76","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nat. Med"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB77","series-title":"Calpain: Pharmacology and Toxicology of Calcium-Dependent Protease","first-page":"77","article-title":"Calpain substrates, assay methods, regulation, and its inhibitory agents","author":"Wang","year":"1999"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0166-2236(99)01479-4","article-title":"Calpain and caspase: can you tell the difference?","volume":"23","author":"Wang","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-0102(03)00195-0","article-title":"Poly-arginine-fused calpastatin peptide, a living cell membrane-permeable and specific inhibitor for calpain","volume":"47","author":"Wu","year":"2003","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB80","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/90242","article-title":"The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors","volume":"19","author":"Xia","year":"2001","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.expneurol.2004.03.018_BIB81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/08977150360517182","article-title":"Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection","volume":"20","author":"Zhang","year":"2003","journal-title":"J. Neurotrauma"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T06:12:22Z","timestamp":1623910342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488604001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0014488604001244"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.03.018","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}